Bumper Offer - Urjas oil Just @ Rs. 1
Telmikind 40 Tablet (10), a prescription drug, is manufactured in various forms such as Tablet. It is typically used for the treatment of Heart Failure, High BP. The alternative uses of Telmikind 40 Tablet (10) have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Telmikind 40 Tablet (10). The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Common side effects of Telmikind 40 Tablet (10) include Dizziness, Nausea or vomiting, Back Pain. Apart from the aforementioned side effects, Telmikind 40 Tablet (10) can also lead to other problems, which have been listed below. Usually, these side effects of Telmikind 40 Tablet (10) go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Telmikind 40 Tablet (10)'s effect during pregnancy is Severe and Mild while nursing. Warnings related to Telmikind 40 Tablet (10)'s effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Angioedema, Hyperkalemia, Drug Allergy must refrain from the use of Telmikind 40 Tablet (10) since this can cause severe adverse effects.
Besides this, Telmikind 40 Tablet (10) may also have severe interaction with some medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Telmikind 40 Tablet (10) is considered not safe while driving, and is not addictive.
Telmikind 40 Tablet (10) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Telmikind 40 Tablet (10) safe for pregnant women?
Telmikind shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Telmikind 40 Tablet (10) safe during breastfeeding?
Breastfeeding women can take Telmikind as it bears very minor side effects for them.
What is the effect of Telmikind 40 Tablet (10) on the Kidneys?
Telmikind does not damage the kidneys.
What is the effect of Telmikind 40 Tablet (10) on the Liver?
Telmikind is rarely harmful for the liver.
What is the effect of Telmikind 40 Tablet (10) on the Heart?
Side effects of Telmikind rarely affect the heart.
Telmikind 40 Tablet (10) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Telmikind 40 Tablet (10) unless your doctor advises you to do so -
Is this Telmikind 40 Tablet (10) habit forming or addictive?
No, you will not get addicted to Telmikind 40 Tablet (10).
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Telmikind 40 Tablet (10) as you may feel sleepy.
Is it safe?
Yes, but consume Telmikind 40 Tablet (10) only on doctor's advice.
Is it able to treat mental disorders?
Telmikind 40 Tablet (10) is unable to treat or cure mental disorders.
Interaction between Food and Telmikind 40 Tablet (10)
Eating certain foods may increase the time it takes Telmikind 40 Tablet (10) to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Telmikind 40 Tablet (10)
Consult your doctor before consuming alcohol while taking Telmikind 40 Tablet (10) as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
